Viatris Inc (NASDAQ:VTRS)

11.68
Delayed Data
As of May 19
 +0.41 / +3.64%
Today’s Change
9.66
Today|||52-Week Range
15.95
-13.67%
Year-to-Date
VTRS Regular Dividend: VTRS will begin trading ex-dividend on 05/23/22 with a $0.12 dividend payable to shareholders of record as of 05/24/22.
BERKSHIRE ASSET MANAGEMENT LLC/PA's Top 5 Sells of the 1st Quarter
May 18 / GuruFocus News - Paid Partner Content
Why Viatris Stock Is Popping Today
May 09 / MotleyFool.com - Paid Partner Content
COURAGE CAPITAL MANAGEMENT LLC Buys 1, Sells 4 in 1st Quarter
May 18 / GuruFocus News - Paid Partner Content
Viatris' (VTRS) Q1 Earnings Beat, Revenues Miss Estimates
May 09 / Zacks.com - Paid Partner Content
2 Stocks That Are Ridiculously Cheap Right Now
May 14 / MotleyFool.com - Paid Partner Content
Viatris (VTRS) Q1 Earnings Beat Estimates
May 09 / Zacks.com - Paid Partner Content
3 Dirt-Cheap Stocks You Can Buy Right Now
May 14 / MotleyFool.com - Paid Partner Content
Theravance's (TBPH) Q1 Earnings and Sales Miss Estimates
May 06 / Zacks.com - Paid Partner Content
Chris Davis Whittles Down Top Holding Wells Fargo, Adds to Meta Platforms Stake
May 13 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close11.27
Today’s open11.12
Day’s range11.11 - 11.79
Volume1,084,821
Average volume (3 months)13,332,259
Market cap$13.4B
Data as of 4:03pm ET, 05/19/2022

Growth & Valuation

Earnings growth (last year)+5.78%
Earnings growth (this year)-55.76%
Earnings growth (next 5 years)+0.13%
Revenue growth (last year)+49.53%
P/E ratio83.4
Price/Sales0.92
Price/Book0.65

Competitors

----
ALNYAlnylam Pharmaceutic...+1.10+0.86%
INCYIncyte Corp+0.95+1.29%
BHVNBiohaven Pharmaceuti...-0.65-0.46%
Data as of 4:03pm ET, 05/19/2022

Financials

Next reporting dateAugust 8, 2022
EPS forecast (this quarter)$0.83
Annual revenue (last year)$17.9B
Annual profit (last year)-$1.3B
Net profit margin-7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Canonsburg, Pennsylvania

Forecasts